RETA 30-in stock soon

This product is intended for research purposes only

Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required. 

RESEARCH INDICATES THAT RETATRUTIDE MAY BE THE MOST EFFECTIVE WEIGHT LOSS PEPTIDE YET DEVELOPED WITH SOME STUDIES SHOWING RAPID AND SUSTAINED WEIGHT LOSS RESPONSE AS HIGH AS 24% OF TOTAL BODY WEIGHT.   IT IS THOUGHT TO PROMOTE WEIGHT LOSS BY INCREASING ENERGY EXPENDITURE AS WELL AS DECREASING ENERGY CONSUMPTION.  IT DOES THE FORMER VIA ACTION AT THE GLUCAGON RECEPTOR AND THE LATTER THROUGH BOTH CENTRAL AND PERIPHERAL APPETITE CONTROL.